Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Fourth Quarter Sales Exceed $1 Million

Premium

CAMBRIDGE, Mass.-- Spotfire, a bioinformatics software provider, reported that its fourth quarter earnings in 1998 exceeded $1 million and that the company gained 11 new customers during the quarter, including Ariad Pharmaceuticals, Bristol-Myers Squibb, and Rohm and Haas.

Spotfire said sales of its suite of research and development discovery software have jumped dramatically during the past six months, and that its 134 customers include 19 of the top 22 pharmaceutical companies. The company reported that sales were spurred by the addition to its product line of Spotfire Discovery Server, which includes flagship product Spotfire Pro as well as Structure Visualizer and Decision Explorer.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.